腹横肌松解联合永久合成补片术后的长期临床与患者报告结局:1203例单中心分析
该研究回顾性分析单中心1203例择期开放腹壁疝修补联合腹横肌松解(TAR)与永久合成补片患者的长期结局。中位随访2年,复合疝复发率为26%,敏感分析最佳与最差情形分别为5%与28%。无论是否复发,患者疝特异性生活质量和疼痛均有改善,未复发者改善更显著。
要点
- TAR联合永久合成补片后中位2年复合疝复发率为26%。
- 敏感分析显示复发率最佳情形5%、最差情形28%。
- 无论复发与否,患者生活质量和疼痛均有改善。
核心结论
- TAR联合永久合成补片仍是有价值且通用的技术,但需对长期耐久性持审慎预期。
- 尽管复发率较高,患者的生活质量仍有可测量的改善。
研究设计与样本
- 回顾性分析Cleveland Clinic腹壁核心健康中心前瞻性登记数据。
- 纳入2014年8月至2020年3月择期开放腹壁疝修补联合TAR与永久合成补片、有30天临床随访及至少1年临床或患者报告结局随访的患者,共1203例。
主要发现
- 中位年龄60岁(IQR 52-67),中位BMI 32 kg/m²(IQR 28-36),中位疝宽度15 cm(IQR 12-19),57%为复发性疝。
- 筋膜重新对合率为92%。
- 中位随访2年(IQR 1-4),总体复合疝复发率为26%,敏感分析最佳与最差情形分别为5%与28%。
- 无论是否复发,患者疝特异性生活质量和疼痛均有改善,未复发者改善更显著。
临床怎么用
- 术前应与患者充分沟通TAR联合永久合成补片后长期复发风险。
- 术后应关注患者报告的生活质量和疼痛改善,即使发生复发。
局限性
- 为单中心回顾性登记数据分析。
- 中位随访仅2年,长期耐久性数据仍不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to report long-term clinical and patient-reported outcomes of transversus abdominis release (TAR) with permanent synthetic mesh performed in a high-volume abdominal wall reconstruction practice. SUMMARY BACKGROUND DATA: Despite increasing utilization of TAR in abdominal wall reconstruction, long-term clinical and patient-reported outcomes remain uncertain. METHODS: Prospectively collected registry data from the Cleveland Clinic Center for Abdominal Core Health were analyzed retrospectively. Patients undergoing elective, open VHR with TAR and permanent synthetic mesh implantation between August 2014 and March 2020 with 30-day clinical and ≥1 year clinical or patient-reported outcome follow-up were included. Outcomes included composite hernia recurrence, characterized by patient-reported bulges and recurrent hernias noted on physical exam or imaging, as well as hernia-specific quality of life and pain. RESULTS: A total of 1203 patients were included. Median age was 60 years [interquartile range (IQR): 52-67], median body mass index was 32 kg/m 2 (IQR: 28-36), median hernia width was 15 cm (IQR: 12-19), and 57% of hernias were recurrent. Fascial reapproximation was achieved in 92%. At a median follow-up of 2 years (IQR: 1-4), the overall composite hernia recurrence rate was 26%, with sensitivity analysis yielding best-case and worst-case estimates of 5% and 28%, respectively. Patients experienced improved hernia-specific quality of life and pain regardless of recurrence outcome; however, those who did not recur experienced more substantial improvement. CONCLUSIONS: TAR with permanent synthetic mesh remains a valuable, versatile technique; however, surgeon and patient expectations should be tempered regarding long-term durability. Despite a high rate of recurrence, patients experience measurable improvements in quality of life.
引用
- Zolin SJ, Krpata DM, Petro CC, et al. Long-term Clinical and Patient-Reported Outcomes After Transversus Abdominis Release With Permanent Synthetic Mesh: A Single Center Analysis of 1203 Patients. Ann Surg. 2022. PMID: 35793810. doi:10.1097/SLA.0000000000005443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。